MolNFT v1 · #105912 · protein
EGFR kinase (T790M/L858R) with inhibitor compound 5
4RJ5 · Epidermal growth factor receptor: “EGFR kinase (T790M/L858R) with inhibitor compound 5”. X-ray diffraction, 1 ligand (3QY), 4 pockets (best druggability 0.55). MolNFT v1 #105912 on GenesisL1: 3D structure, binding sites and pockets…
- PDB
- 4RJ5
- Type
- protein
- Length
- 296 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Epidermal growth factor receptor
- EC
- 2.7.10.1
- UniProt
- P00533
- Ligands
- 3QY
- Pockets
- 4 · best druggability 0.55
Structure
x-ray diffraction · 1 distinct chain · 39% helix, 16% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Epidermal growth factor receptor (EC 2.7.10.1) | protein | 296 | 39% helix, 16% strand | P00533 |
Ligands and binding sites
- 3QY · N-[2-(4-methoxypiperidin-1-yl)pyrimidin-4-yl]-2-(1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 242 | 0.55 | 0.77 | 25 | 3QY |
| 2 | 143 | 0.49 | 0.79 | 20 | empty |
| 3 | 141 | 0.44 | 0.75 | 19 | empty |
| 4 | 64 | 0.29 | 0.74 | 14 | empty |
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P00533
- Elsewhere: RCSB PDB 4RJ5 · PDBe 4RJ5 · UniProt P00533
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.